US Soon to Get Covid Tablet

According to reports Merck may launch new covid-19 Tablet in the US markets shortly. It is expected that that the Tablet will be available before Christmas. The new under development by Merck is aimed at breaking the rapid spread course of covid-19 in America. Also, reports say that Pfizer is expected to release second antiviral pill shortly following Merck’s release.

Both the drugs are currently under regulatory review and following approval may produce the pills at commercial scale. Both the firms aim to increase production capacity of covid-19 vaccines and vaccinate people against covid-19. The company not just aims to increase production capacity of covid-19 vaccine but also increase vaccine manufacturing capacity for other infectious diseases and serve the ongoing global health needs.

The news was of the new pills launch was released at the conference called “game-changer”. The pills that require to be taken 30 or 40 in a five day course have showed significant reduction in hospitalization rate and fatality in the clinical trials according to the researchers.The antiviral drug Molnupiravir which is mainly aimed at addressing the covid-19 infections has successfully shown to treat high-risk adult patients who had been hospitalized and not been vaccinated by covid-19 vaccine after few days of covid-19 symptoms.

The findings showed that the medication of the drug decreased the hospitalization rate and mitigated the danger of death. The drug may also act against the influenza infection. Reports say that Merck may launch new covid-19 Tablet in the US markets shortly. It is expected that that the Tablet will be available before Christmas